PAR-21-315 - Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech |
NOT-NS-23-002 |
NINDS , NCCIH , NCI , NEI , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCR , NIMH
|
Aug 3, 2022 |
Jun 21, 2024
|
U44, UG3/UH3 |
Notice of Special Interest (NOSI): BRAIN Initiative: Translation of Groundbreaking Technologies from Early-stage Development through Early Clinical Study via Blueprint MedTech |
NOT-NS-22-052 |
NINDS , NIAAA , NIBIB , NCCIH , NEI , NIA , NICHD , OBSSR , NIDCD , NIDA , NIMH
|
Jan 5, 2022 |
Jun 21, 2024
|
U44, UG3/UH3 |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI) in Migraine and Headache Research |
NOT-NS-22-051 |
NINDS
|
Dec 27, 2021 |
May 8, 2022
|
U01, K01, UG3/UH3, K22, K99/R00, K02, K08, R01, F30, K23, F32, R21, F31, R61/R33 |
Notice of Special Interest (NOSI) in NINDS mission relevant Pain Research |
NOT-NS-22-050 |
NINDS
|
Dec 27, 2021 |
May 8, 2022
|
K01, UG3/UH3, K99/R00, K22, K08, R01, K02, F30, K23, R21, F32, F31, U01, U24, R61/R33 |
|